Selection between sunitinib and ripretinib using mutation analysis for gastrointestinal stromal tumor patients progressing on imatinib

被引：0
|
作者：
Joensuu, Heikki [1 ,2 ]
机构：
[1] Helsinki Univ Hosp, Dept Oncol, POB 180,Haartmaninkatu 4, Helsinki 00029, Finland
[2] Univ Helsinki, POB 180,Haartmaninkatu 4, Helsinki 00029, Finland
来源：
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY | 2024年 / 9卷
关键词：
Gastrointestinal stromal tumor (GIST); imatinib; sunitinib; ripretinib; PHASE-II TRIAL; KINASE INHIBITOR; EFFICACY; KIT; RESISTANCE; SCHEDULE; MESYLATE; SAFETY;
D O I：
10.21037/tgh-24-32
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Efficacy evaluation of imatinib treatment in patients with gastrointestinal stromal tumors: A meta-analysis
    Chen, Ping
    Zong, Liang
    Zhao, Wei
    Shi, Lei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (33) : 4227 - 4232
  • [42] Relative Factors Analysis of Imatinib Trough Concentration in Chinese Patients with Gastrointestinal Stromal Tumor
    Wu, Xingye
    Li, Juan
    Zhou, Yi
    Mao, Yun
    Luo, Shiqiao
    He, Xuemei
    Wang, Li
    Shen, Yifan
    Zhang, Hua
    Yang, Longwei
    Zhang, Jun
    CHEMOTHERAPY, 2018, 63 (06) : 301 - 307
  • [43] Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenib
    Vincenzi, Bruno
    Nannini, Margherita
    Badalamenti, Giuseppe
    Grignani, Giovanni
    Fumagalli, Elena
    Gasperoni, Silvia
    D'Ambrosio, Lorenzo
    Incorvaia, Lorena
    Stellato, Marco
    Ceruso, Mariella Spalato
    Napolitano, Andrea
    Valeri, Sergio
    Santini, Daniele
    Tonini, Giuseppe
    Casali, Paolo Giovanni
    Dei Tos, Angelo Paolo
    Pantaleo, Maria Abbondanza
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [44] Regorafenib: A Guide to Its Use in Advanced Gastrointestinal Stromal Tumor (GIST) After Failure of Imatinib and Sunitinib
    Lyseng-Williamson, Katherine A.
    BIODRUGS, 2013, 27 (05) : 525 - 531
  • [45] Secondary mutations of c-KIT contribute to acquired resistance to imatinib and decrease efficacy of sunitinib in Chinese patients with gastrointestinal stromal tumors
    Gao, Jing
    Tian, Ye
    Li, Jian
    Sun, Naiping
    Yuan, Jiajia
    Shen, Lin
    MEDICAL ONCOLOGY, 2013, 30 (02)
  • [46] KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib
    Joensuu, Heikki
    CANCERS, 2023, 15 (15)
  • [47] Regorafenib: A Guide to Its Use in Advanced Gastrointestinal Stromal Tumor (GIST) After Failure of Imatinib and Sunitinib
    Katherine A. Lyseng-Williamson
    BioDrugs, 2013, 27 : 525 - 531
  • [48] Is exon mutation analysis needed for adjuvant treatment of gastrointestinal stromal tumor?
    Sendur, Mehmet Ali Nahit
    Ozdemir, Nuriye Yildirim
    Akinci, Muhammed Bulent
    Uncu, Dogan
    Zengin, Nurullah
    Aksoy, Sercan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (01) : 144 - 146
  • [49] The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11+17/18 mutations
    George, Suzanne
    Blay, Jean-Yves
    Chi, Ping
    Jones, Robin L.
    Serrano, Cesar
    Somaiah, Neeta
    Gelderblom, Hans
    Zalcberg, John R.
    Reichmann, William
    Sprott, Kam
    Cox, Paulina
    Sherman, Matthew L.
    Ruiz-Soto, Rodrigo
    Heinrich, Michael C.
    Bauer, Sebastian
    FUTURE ONCOLOGY, 2024, 20 (27) : 1973 - 1982
  • [50] KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients
    Gajiwala, Ketan S.
    Wu, Joe C.
    Christensen, James
    Deshmukh, Gayatri D.
    Diehl, Wade
    DiNitto, Jonathan P.
    English, Jessie M.
    Greig, Michael J.
    He, You-Ai
    Jacques, Suzanne L.
    Lunney, Elizabeth A.
    McTigue, Michele
    Molina, David
    Quenzer, Terri
    Wells, Peter A.
    Yu, Xiu
    Zhang, Yan
    Zou, Aihua
    Emmett, Mark R.
    Marshall, Alan G.
    Zhang, Hui-Min
    Demetri, George D.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (05) : 1542 - 1547
12345